Morea N, Retnakaran R, Vidal J, Aroda VR, et al. iGlarLixi effectively reduces residual hyperglycemia in patients with type 2
diabetes on basal insulin: a post hoc analysis from the LixiLan-L study. Diabetes Obes Metab 2020 May 3. doi: 10.1111/dom.14077.
PMID: 32363634